The weekly litigation news digest is live. Subscribe now

IP Verse

Combination Therapy Using Liposomal Irinotecan And A Parp Inhibitor For Cancer Treatment - EP3337467

The patent EP3337467 was granted to Ipsen Biopharm on Dec 9, 2020. The application was filed on Aug 19, 2016 under application number EP16757498A. The patent is currently recorded with a legal status of "Revoked".

EP3337467

IPSEN BIOPHARM
Application Number
EP16757498A
Filing Date
Aug 19, 2016
Status
Revoked
Aug 11, 2023
Publication Date
Dec 9, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
SANDOZSep 9, 2021LEDERER & KELLER PATENTANWALTE PARTNERSCHAFT MBB -

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents